Le mycosis fongoide et son paradigme renove.

Administration, Cutaneous; Belgium/epidemiology; Diagnosis, Differential; Glucocorticoids/administration & dosage/therapeutic use; Humans; Incidence; Mycosis Fungoides/epidemiology/pathology/therapy; Neoplasm Staging; Phototherapy; Prevalence; Prognosis; Skin Neoplasms/epidemiology/pathology/therapy; Survival Rate; T-Lymphocytes/pathology

Abstract :

[en] Primary cutaneous lymphomas are distinguished by singular clinical, histological and prognostic features that are not shared by other lymphomas originating from the lymphoid tissues. This review is an update of the current concepts about the biology, diagnosis and treatment of mycosis fungoides, the most frequent entity among the primary cutaneous T cell lymphomas. It is currently established that mycosis fungoides originates from T lymphocytes normally homing the dermis. Such a situation implies that treatments at least in the initial stages of the disease, should primarily target the skin without searching for an impact on internal lymphoid tissues.

Disciplines :

Dermatology

Author, co-author :

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Le mycosis fongoide et son paradigme renove.

Alternative titles :

[en] Mycosis fungoides and its new paradigm

Publication date :

2010

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Hopital de Baviere, Liège, Belgium

Volume :

Issue :

Pages :

147-51

Peer reviewed :

Peer reviewed

Available on ORBi :

since 10 August 2010

Statistics

Number of views

130 (7 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Burg G, Kempf W, Cozzio A, et al. - WHO/EORTC classification of cutaneous lymphomas 2005: histolo-gical and molecular aspects. J Cutan Pathol, 2005, 32, 647-674.
Willemze R, Jaffe ES, Burg G, et al. - WHO-EORTC classification for cutaneous lymphomas. Blood, 2005, 105, 3768-3785.
Quatresooz P, Piérard-Franchimont C, Piérard GE. - Comment j'explore⋯ un lymphome T cutané. Nou-veaux horizons. Rev Med Liège, 2008, 63, 208-212.
Criscione VD, Weinstock A. - Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol, 2007, 143, 854-859.
Nikkels AF, Quatresooz P, Delvenne P, et al. - Mycosis fungoides progression and chronic solvent exposure. Dermatology, 2004, 208, 171-172.
Grob JJ. - Epidémiologie du mycosis fongoïde. Ann Dermatol Venereol, 2005, 132, S11-S12.
Gallardo F, Garcia-Muret M P, Servitje O, et al. - Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases. J Eur Acad Dermatol Venereol, 2009, 23, 639-647.
Piérard GE, Piérard-Franchimont C, Hermanns-Lê T, et al. - Factor XIIIa positive dendritic cells in mycosis fungoides. Cancer J, 1992, 5, 226-229.
Fivenson D P, Nickoloff BJ. - Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis. J Cutan Pathol, 1995, 22, 223-228.
Piérard GE, Piérard-Franchimont C. - Pattern of distribution and intensity of blastogenesis as clues for distinguishing pseudolymphomas from lymphomas. Br J Dermatol, 1983, 109, 253-259.
Piérard-Franchimont C, Piérard GE. - Comment je traite⋯ un patient atteint de mycosis fongoïde. Rev Med Liège, 2006, 61, 740-746.
Oshtory S, Apisarnthanarax N, Gilliam AC, et al. - Usefulness of flow cytometry in the diagnosis of mycosis fungoides. J Am Acad Dermatol, 2007, 57, 454-462.
Quatresooz P, Piérard-Franchimont C, C. Devillers, Piérard GE. - Pseudolymphomes cutanés et pseudoclona-lité des infiltrats lymphoïdes. Rev Med Liège, 2009, 64, 581-586.
Cordel N, Lenormand B, Courville P, et al. - Usefulness of cutaneous T cell clonality analysis for the diagnosis of cutaneous T cell lymphoma in patients with erythro-derma. Arch Pathol Lab Med, 2005, 129, 372-376. (Pubitemid 40343993)
Van Doom R, Van Haselen C W, VanVoorst PC, et al. - Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol, 2000, 136, 504-510.
Kim YH, Liu HL, Mraz-Gernhard S, et al. - Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical pronostic factors and risk for disease progression. Arch Dermatol, 2003, 139, 857-866. (Pubitemid 36898920)
Grange F. - Pronostic des lymphomes T cutanés primi-tifs. Ann Dermatol Venereol, 2005, 132, S13-S20.
Trautinger F, Knobler R, Willemze R, et al. - EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer, 2006, 42, 1014-1030.
Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. - Joint British association of dermatologists and UK cutaneous lymphoma group guidelines for the management of primary cutaneous T cell lymphomas. Br J Dermatol, 2003, 149, 1095-1107. (Pubitemid 38058085)
Dummer R, Assaf C, Bagot M, et al. - Maintenance therapy in cutaneous T-cell lymphoma: who, when, what? Eur J Cancer, 2007, 43, 2321-2329. (Pubitemid 350001246)